Skip Navigation
Skip to contents

ACC : Acute and Critical Care

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > Acute Crit Care > Volume 39(2); 2024 > Article
Review Article
Basic science and research
Sex or gender differences in treatment outcomes of sepsis and septic shock
Seung Yeon Min1orcid, Ho Jin Yong1orcid, Dohhyung Kim2orcid
Acute and Critical Care 2024;39(2):207-213.
DOI: https://doi.org/10.4266/acc.2024.00591
Published online: May 24, 2024

1Department of Internal Medicine, Dankook University Hospital, Cheonan, Korea

2Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Dankook University Hospital, Dankook University College of Medicine, Cheonan, Korea

Corresponding author: Dohhyung Kim Department of Internal Medicine, Dankook University College of Medicine, 119 Dandae-ro, Dongnam-gu, Cheonan 31116, Korea Tel: +82-41-550-3870 Fax: +82-41-556-3256 E-mail: kimdh@dankook.ac.kr
*These authors contributed equally to this study.
• Received: April 3, 2024   • Revised: April 12, 2024   • Accepted: April 12, 2024

© 2024 The Korean Society of Critical Care Medicine

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 577 Views
  • 57 Download
  • Gender disparities in intensive care unit (ICU) treatment approaches and outcomes are evident. However, clinicians often pay little attention to the importance of biological sex and sociocultural gender in their treatment courses. Previous studies have reported that differences between sexes or genders can significantly affect the manifestation of diseases, diagnosis, clinicians' treatment decisions, scope of treatment, and treatment outcomes in the intensive care field. In addition, numerous reports have suggested that immunomodulatory effects of sex hormones and differences in gene expression from X chromosomes between genders might play a significant role in treatment outcomes of various diseases. However, results from clinical studies are conflicting. Recently, the need for customized treatment based on physical, physiological, and genetic differences between females and males and sociocultural characteristics of society have been increasingly emphasized. However, interest in and research into this field are remarkably lacking in Asian countries, including South Korea. Through this review, we hope to enhance our awareness of the importance of sex and gender in intensive care treatment and research by briefly summarizing several principal issues, mainly focusing on sex and sex hormone-based outcomes in patients admitted to the ICU with sepsis and septic shock.
Sex and gender are essential in epidemiologic data in almost all clinical research papers. However, most clinicians ignore the distinction between these two terms and often pay little attention to the clinical importance of sex and gender when they treat patients. Sex is a term that describes biological differences between sexes, reflecting sex chromosomes, sex hormones, and anatomical structures between males and females and resulting differences in physiological characteristics, while gender is a term that reflects sociocultural factors, such as differences in gender identity (man and woman, boy and girl), societal roles and status, and behavioral patterns of genders [1]. With a sociocultural base, gender reflects differences in gender-specific medical demand, accessibility to medical services, and service provision methods [2].
Previous studies have reported that biological and sociocultural differences between males and females can significantly affect the diagnosis of diseases, clinicians' decisions about treatment, scope of treatment, and the incidence and manifestations of disease [3,4]. In the intensive care field, it has been reported that the complex interaction between sex and gender has a significant impact on disease manifestations, treatment responses, and patient outcomes [3]. While most studies on sex or gender differences in disease presentation and treatment behaviors in intensive care units (ICUs) have been conducted in western countries, studies conducted in Asian countries with a Confucian culture, such as South Korea, are scarce. However, as the demand for customized treatment based on individual characteristics increases, researchers and clinicians are paying more attention to sex and gender as essential variables. Reflecting this, in 2016, the United States National Institutes of Health (US NIH) recommended that sex be included as an essential biological variable in all animal or cell research [5,6]. The Canadian Institutes of Health Research also published guidelines emphasizing the importance of sex and gender in biomedical research [1].
Male sex is a well-known possible risk factor for sepsis and septic shock. Sepsis is more prevalent in men than in women, showing an annual relative risk of 1.3 times that of women [7]. In addition, among septic shock patients admitted to ICUs, males were more prevalent than females. Men also showed longer length of ICU stay, longer duration of hospitalization, higher ICU mortality, higher likelihood of readmission within 90 days and 1 year, and more frequent death at 1 year after the event of sepsis [8,9]. Although the possible mechanism explaining sex difference in manifestation of sepsis remains unclear, beneficial roles of many genes and their products expressed from a silent X chromosome in women and sex hormones such as estrogen in the regulation of immune responses in sepsis have been suggested [10,11].
Through this review, we hope to enhance awareness of the importance of sex and gender in intensive care treatment and research by briefly summarizing principal issues, mainly focusing on sex and sex hormone-based differences in treatment outcomes of patients admitted to the ICU with sepsis and septic shock.
Estrogen is a sex hormone that regulates the development and function of the female reproductive system. Before menopause, estrogen is mainly synthesized in the ovaries. After menopause, it is produced in adipose tissues (breasts), brain, kidneys, liver, and bones [12]. In men, estrogen is produced primarily in the testes. The proportion of estrogen produced in secondary tissues is relatively higher in men than in women [13]. Among four types of estrogens (estrone, estradiol, estriol, and etestrol), estradiol is the most potent. It can bind to estrogen receptors in the nucleus, plasma membrane, and endoplasmic reticulum and exert its functions through genomic and non-genomic mechanisms [14,15]. There are currently three known estrogen receptors: estrogen receptor alpha (ERα), estrogen receptor beta (ERβ), and guanine nucleotide-binding protein-coupled estrogen receptor 1 (CPER1/CPR30) [16]. Estradiol participates in the regulation of proinflammatory signaling/pathways in the immune system. It acts mainly as an anti-inflammatory agent through ERα and CPER1 [17,18] and has various anti-inflammatory and proinflammatory functions through ERβ [19,20]. Diverse effects of estrogen on inflammation are believed to be due to various expression levels of estrogen receptor based on cell type and physiological state [21].
Protective Effects of Estrogen Against Sepsis
Evidence supporting the protective effects of estrogen has been accumulating for several decades. Most of these data are associated with dampening the hyperinflammatory state of sepsis by reducing expression levels of circulating proinflammatory cytokines such as interleukin (IL)-6 and tumor necrosis factor (TNF)-α [21].
Experiments using proestrus female mice in a cecal ligation sepsis model demonstrated that immune functions of preserved splenocytes are associated with better survival [22]. Addition of 17β-estradiol to splenocytes from ovariectomized female mice normalized immune functional capacities in a trauma-hemorrhage model [23]. Another study performed with a mouse model of hemorrhage and subsequent sepsis showed a greater increase in plasma proinflammatory cytokines including IL-6, TNF-α, and prostaglandin E2 in male mice than proestrus female mice. They also showed a survival advantage of female sex hormones against subsequent septic challenge [24]. In addition, less pronounced cardiac dysfunction was seen in female mice than in male mice in a cecal ligation and puncture (CLP) sepsis model [25]. In that study, female mice showed decreased production of TNF-α, IL-6, and inducible nitric oxide synthase. Cardioprotective effects were shown in ovariectomized female mice after administration of landiolol in a CLP sepsis model. Such effects were assumed to be due to overexpression of genes involved in calcium influx. In contrast, inactivation of the β-adrenergic and a calcium efflux pathway was seen in control females [25]. The protective effect of estrogen against liver damage in sepsis has also been observed in a lipopolysaccharide (LPS)-induced sepsis model. Female septic mice showed liver damage with increased serum aspartate aminotransferase and alanine aminotransferase levels as well as extensive necrosis, and both were more severe in male septic mice. In addition, ovariectomy-aggravated sepsis-induced liver damage and activation of the pyroptosis signaling pathway could be alleviated by estrogen [26].
Suppressive Effects of Testosterone on the Immune System in Sepsis
Sex-dependent differences in the incidence and severity of sepsis make males more susceptible to septic shock than females. Testosterone is a primary male sex hormone and has also been implicated in sex-dependent differences in sepsis. Testosterone has significant immunosuppressive effects on innate and adaptive immunity by reducing immunoglobulin, cytokine production, and lymphocyte proliferation [27,28]. LPS-induced TNF-α secretion in plasma was significantly enhanced in rats receiving neonatal androgen blockade with flutamide and in prepubertal orchiectomies rats, suggesting testosterone's immunosuppressive role in inflammation [29]. Another study showed that orchiectomized mice were significantly more susceptible to endotoxic shock, and that macrophages isolated from them had significantly higher toll-like receptor-4 cell surface expression than those derived from sham gonadectomized mice. However, these effects were dampened in orchiectomized mice receiving exogenous testosterone [30]. Although the details of the underlying molecular mechanisms remain unclear, effects of androgen receptor blockade are thought to be partly attributable to the upregulation of estrogen receptors or enhanced estrogen receptor-related pathways [31-33].
Epidemiologic Differences Based on Sex
A higher prevalence of sepsis in men than in women has been reported in various nationwide or individual hospital-based epidemiologic studies [34]. A longitudinal, population-based epidemiological study of sepsis from 2005 to 2012 using the Korean National Health Insurance Service-National Sample Cohort—a population-based cohort representing 2.2% of the Korean population—reported that 53.5% to 58.0% of a total of 22,882 sepsis cases were males. It also found that female sex was an independent favorable risk factor for 6-month mortality in multivariate logistic regression analysis, showing an odds ratio (OR) of 0.7 (95% confidence interval [CI], 0.66–0.76; P<0.001) [35]. Potential mechanisms explaining the higher prevalence of sepsis in men are unclear. However, the combination of biological sex differences, such as the immune system, sex hormones, gene expression from a silent X-chromosome, anatomical differences, and pharmacokinetics and dynamics for drugs [10,11,36,37], and sociocultural gender differences in disease perception, risk behavior, accessibility to and use of healthcare resources, and service provision methods are thought to play a critical role in sex disparities in sepsis [38-40].
Sex Preference in the Source of Bacterial Infections
Sexual differences in bacterial infections have been reported in human and animal models. Diverse manifestations and outcomes of infections based on sex are intricately linked to genetic, biological, and behavioral differences, which are associated with gender preferences of specific bacterial infections, sex hormones, and immune responses by sex [41,42]. In general, men are more susceptible to gastrointestinal and respiratory bacterial diseases and sepsis, while women are more susceptible to genitourinary tract infections [43]. Recent studies have reported that tissue-specific expression of sex hormone receptors contributes to the sexual disparity in bacterial infections [43]. According to a prospective observational study on community-acquired severe sepsis and septic shock conducted in 12 university hospitals in South Korea, among a total of 1,192 patients, gastrointestinal (26.8% vs. 20.9%), respiratory (39.2% vs. 19.2%), and skin and soft tissue (11.0% vs. 4.7%) infections as a source of primary infection were higher in men (men vs. women), while urinary tract infection (11.4% vs. 44.8%) was more prevalent in women (P<0.05 for each) [44].
Sex Differences in Outcomes of Sepsis and Septic Shock
Numerous individual and nationwide studies have evaluated the relationship between sex and mortality from sepsis and septic shock. However, evidence showing an association of sepsis mortality with specific sex is conflicting. Although preclinical studies have suggested potential protective effects of estrogen on sepsis, some studies have shown higher mortality rates in women with sepsis [45-48]. In comparison, others have shown higher mortality rates in men with sepsis [49-51]. Furthermore, some studies have reported no difference in mortality rate from sepsis and septic shock between sexes [52-54]. According to a recently published meta-analysis including 13 studies with 80,520 participants, there were no sex-based differences in all-cause hospital mortality (OR, 1.02; 95% CI, 0.79–1.32; very low-certainty evidence) or all-cause ICU mortality (OR, 1.19; 95% CI, 0.79–1.78; very low-certainty evidence). Interestingly, however, females presented higher 28-day all-cause mortality (OR, 1.18; 95% CI, 1.05–1.32; very low-certainty evidence) and lower 1-year all-cause mortality (OR, 0.83; 95% CI, 0.68–0.98; low-certainty evidence) [55]. An epidemiologic study for severe community-acquired sepsis and septic shock conducted in South Korea reported that 28-day mortality (27.0% vs. 18.1%), in-hospital mortality (32.9% vs. 22.0%), and sepsis-related mortality (28.3% vs. 18.1%) were lower in females (P<0.001 for each) [44]. Several explanations have been suggested for these disparate findings in clinical studies of sex differences in sepsis and septic shock. The most critical issues were heterogeneous study designs (prospective vs. retrospective, single vs, multicenter or nationwide database), different definitions of sepsis, different baseline health statuses, comorbidities, severity of sepsis, age, and sociocultural differences affecting treatment attitudes for men and women [56]. Among these, age is a critical factor to consider when assessing the protective effects of estrogen against sepsis. Level of estradiol, the most potent estrogen, is highest in women between prepuberty and menopause. In contrast, the prevalence of sepsis and septic shock is significantly higher in patients over 60 years of age. Multiple comorbidities are also more common in these patients. Thus, when evaluating effects of sex factors on outcomes of sepsis, age stratification and control of confounding factors such as comorbidities should be considered [56]. In a study conducted on 143 polytraumatized patients with injury severity score >16 and between 16 and 65 years old, the prevalence of multiorgan dysfunction syndrome and sepsis was significantly lower in females younger than 50 years with an injury severity score >25 than in age-matched males [57]. However, when focusing on clinical studies specifically examining sex hormones in connection to sepsis patients, results are again conflicting. Higher circulating estradiol levels were associated with higher mortality rates in both male and female patients, and elevated serum estradiol levels were associated with the severity of renal dysfunction and the development of acute kidney injury [58-60]. In addition, while levels of proinflammatory cytokines such as TNF-α and IL-6 were increased in male patients, anti-inflammatory cytokine IL-10, which was defined as a predictor for the severity of sepsis, was higher in female patients [28,61,62]. Thus, differences in study conclusions might be attributed to differences in sex steroid levels among patients rather than a difference in the type of sex hormones alone.
Many studies have reported that treatment opportunities in the ICU differ depending on gender. Most studies have pointed out that women have a lower tendency to receive advanced life-supporting measures, including early goal-directed treatment for sepsis, mechanical ventilatory support, renal replacement therapy, and other invasive procedures [63,64]. Pharmacokinetic and pharmacodynamic differences between male and female patients have also recently attracted attention from clinicians. Adverse events from medications used in the ICU were more prevalent in female patients. Possible explanations include sex-associated anatomic and physiologic factors, such as lower body weight, higher proportion of fat compared with muscle, and lower plasma volume, which can easily lead to an over-concentration of medicine and toxicity in females [38]. However, considering different physical traits between western and Asian women and the differences in sociocultural attitudes toward female gender between western and Asian countries, gender differences in ICU treatment should be individually evaluated and interpreted based on each country’s sociocultural background.
Many studies have reported that sex or gender differences can affect the perception and manifestation of the disease, treatment decision, response to treatment, and outcomes in patients admitted to the ICU. Among them, the immunomodulating effects of sex hormones and differences in sex-specific gene expression potentially play an important role in treatment outcomes of sepsis and organ dysfunction in animal studies. However, results in human studies are conflicting. In clinical research, sex or gender differences in outcomes of sepsis patients are further confused by the differences in diagnosis and treatment provision depending on sociocultural background. Even if the need for customized treatment based on an individual’s characteristics has been increasingly emphasized based on physical, physiological, and genetic differences between women and men at a time when sociocultural considerations are necessary, interest and research in this field are remarkably lacking in Asian countries, including South Korea. Therefore, future research targeting septic patients in the ICU is needed to reflect characteristics of biological sex and sociocultural gender based on sociocultural background.
• As the demand for customized treatment based on individual characteristics increases, researchers and clinicians should increase their awareness of the critical role of biological sex and sociocultural gender.
• Although the possible mechanism explaining sex-different manifestations and outcomes of sepsis remains unclear, the beneficial roles of gene expression from a silent X chromosome and sex hormones in regulating immune responses in sepsis have been suggested.
• Future research targeting intensive care unit care must reflect characteristics of biological sex and sociocultural gender based on sociocultural background.

CONFLICT OF INTEREST

Dohhyung Kim is an editorial board member of the journal but was not involved in the peer reviewer selection, evaluation, or decision process of this article. No other potential conflicts of interest relevant to this article were reported.

FUNDING

None.

ACKNOWLEDGMENTS

None.

AUTHOR CONTRIBUTIONS

Conceptualization: DK. Data curation: HJY. Writing–original draft: SYM, HJY. Writing–review & editing: DK.

  • 1. Canadian Institutes of Health Research. How to integrate sex and gender into research [Internet]. Canadian Institutes of Health Research. 2019;[cited 2024 Apr 1]. Available from: https://cihr-irsc.gc.ca/e/50836.html.
  • 2. Shannon G, Jansen M, Williams K, Cáceres C, Motta A, Odhiambo A, et al. Gender equality in science, medicine, and global health: where are we at and why does it matter? Lancet 2019;393:560-9.ArticlePubMed
  • 3. Mauvais-Jarvis F, Bairey Merz N, Barnes PJ, Brinton RD, Carrero JJ, DeMeo DL, et al. Sex and gender: modifiers of health, disease, and medicine. Lancet 2020;396:565-82.ArticlePubMedPMC
  • 4. Regitz-Zagrosek V, Gebhard C. Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes. Nat Rev Cardiol 2023;20:236-47.ArticlePubMedPDF
  • 5. National Institutes of Health. NIH policy and guidelines on the inclusion of women and minorities as subjects in clinical research [Internet]. NIH Central Resource for Grants and Funding Information. 2001;[cited 2024 Apr 1]. Available from: https://grants.nih.gov/policy/inclusion/women-and-minorities/guidelines.htm.
  • 6. National Institutes of Health. Consideration of sex as a biological variable in NIH-funded research [Internet]. National Institutes of Health. 2015;[cited 2024 Apr 1]. Available from: https://grants.nih.gov/grants/guide/notice-files/not-od-15-102.html.
  • 7. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-54.ArticlePubMed
  • 8. Campanelli F, Landoni G, Cabrini L, Zangrillo A. Gender differences in septic intensive care unit patients. Minerva Anestesiol 2018;84:504-8.ArticlePubMed
  • 9. Thompson KJ, Finfer SR, Woodward M, Leong RN, Liu B. Sex differences in sepsis hospitalisations and outcomes in older women and men: a prospective cohort study. J Infect 2022;84:770-6.ArticlePubMed
  • 10. Dias SP, Brouwer MC, van de Beek D. Sex and gender differences in bacterial infections. Infect Immun 2022;90:e0028322.ArticlePubMedPDF
  • 11. Grimaldi CM, Hill L, Xu X, Peeva E, Diamond B. Hormonal modulation of B cell development and repertoire selection. Mol Immunol 2005;42:811-20.ArticlePubMed
  • 12. Cui J, Shen Y, Li R. Estrogen synthesis and signaling pathways during aging: from periphery to brain. Trends Mol Med 2013;19:197-209.ArticlePubMedPMC
  • 13. Cooke PS, Nanjappa MK, Ko C, Prins GS, Hess RA. Estrogens in male physiology. Physiol Rev 2017;97:995-1043.ArticlePubMedPMC
  • 14. Nilsson S, Mäkelä S, Treuter E, Tujague M, Thomsen J, Andersson G, et al. Mechanisms of estrogen action. Physiol Rev 2001;81:1535-65.ArticlePubMed
  • 15. Lösel R, Wehling M. Nongenomic actions of steroid hormones. Nat Rev Mol Cell Biol 2003;4:46-56.ArticlePubMedPDF
  • 16. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005;307:1625-30.ArticlePubMed
  • 17. Giannoni E, Guignard L, Knaup Reymond M, Perreau M, Roth-Kleiner M, Calandra T, et al. Estradiol and progesterone strongly inhibit the innate immune response of mononuclear cells in newborns. Infect Immun 2011;79:2690-8.ArticlePubMedPMCPDF
  • 18. Pelekanou V, Kampa M, Kiagiadaki F, Deli A, Theodoropoulos P, Agrogiannis G, et al. Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ERα36 and GPR30/GPER1. J Leukoc Biol 2016;99:333-47.ArticlePubMedPDF
  • 19. Dupuis ML, Conti F, Maselli A, Pagano MT, Ruggieri A, Anticoli S, et al. The natural agonist of estrogen receptor β silibinin plays an immunosuppressive role representing a potential therapeutic tool in rheumatoid arthritis. Front Immunol 2018;9:1903. ArticlePubMedPMC
  • 20. Rider V, Li X, Peterson G, Dawson J, Kimler BF, Abdou NI. Differential expression of estrogen receptors in women with systemic lupus erythematosus. J Rheumatol 2006;33:1093-101.PubMed
  • 21. Harding AT, Heaton NS. The impact of estrogens and their receptors on immunity and inflammation during infection. Cancers (Basel) 2022;14:909. ArticlePubMedPMC
  • 22. Zellweger R, Wichmann MW, Ayala A, Stein S, DeMaso CM, Chaudry IH. Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med 1997;25:106-10.ArticlePubMed
  • 23. Knöferl MW, Angele MK, Schwacha MG, Bland KI, Chaudry IH. Preservation of splenic immune functions by female sex hormones after trauma-hemorrhage. Crit Care Med 2002;30:888-93.ArticlePubMed
  • 24. Diodato MD, Knöferl MW, Schwacha MG, Bland KI, Chaudry IH. Gender differences in the inflammatory response and survival following haemorrhage and subsequent sepsis. Cytokine 2001;14:162-9.ArticlePubMed
  • 25. Xerri A, Gallardo F, Kober F, Mathieu C, Fourny N, Tran TT, et al. Female hormones prevent sepsis-induced cardiac dysfunction: an experimental randomized study. Sci Rep 2022;12:4939. ArticlePubMedPMCPDF
  • 26. Xu Z, Mu S, Liao X, Fan R, Gao W, Sun Y, et al. Estrogen protects against liver damage in sepsis through inhibiting oxidative stress mediated activation of pyroptosis signaling pathway. PLoS One 2020;15:e0239659.ArticlePubMedPMC
  • 27. Trigunaite A, Dimo J, Jørgensen TN. Suppressive effects of androgens on the immune system. Cell Immunol 2015;294:87-94.ArticlePubMed
  • 28. Angele MK, Pratschke S, Hubbard WJ, Chaudry IH. Gender differences in sepsis: cardiovascular and immunological aspects. Virulence 2014;5:12-9.ArticlePubMed
  • 29. Ongaro L, Castrogiovanni D, Giovambattista A, Gaillard RC, Spinedi E. Enhanced proinflammatory cytokine response to bacterial lipopolysaccharide in the adult male rat after either neonatal or prepubertal ablation of biological testosterone activity. Neuroimmunomodulation 2011;18:254-60.ArticlePubMedPDF
  • 30. Rettew JA, Huet-Hudson YM, Marriott I. Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity. Biol Reprod 2008;78:432-7.ArticlePubMed
  • 31. Yu HP, Yang S, Choudhry MA, Hsieh YC, Bland KI, Chaudry IH. Mechanism responsible for the salutary effects of flutamide on cardiac performance after trauma-hemorrhagic shock: upregulation of cardiomyocyte estrogen receptors. Surgery 2005;138:85-92.ArticlePubMed
  • 32. Hsieh YC, Yang S, Choudhry MA, Yu HP, Bland KI, Schwacha MG, et al. Flutamide restores cardiac function after trauma-hemorrhage via an estrogen-dependent pathway through upregulation of PGC-1. Am J Physiol Heart Circ Physiol 2006;290:H416-23.ArticlePubMed
  • 33. Shimizu T, Yu HP, Hsieh YC, Choudhry MA, Suzuki T, Bland KI, et al. Flutamide attenuates pro-inflammatory cytokine production and hepatic injury following trauma-hemorrhage via estrogen receptor-related pathway. Ann Surg 2007;245:297-304.ArticlePubMedPMC
  • 34. Lakbar I, Einav S, Lalevée N, Martin-Loeches I, Pastene B, Leone M. Interactions between gender and sepsis-implications for the future. Microorganisms 2023;11:746. ArticlePubMedPMC
  • 35. Kim J, Kim K, Lee H, Ahn S. Epidemiology of sepsis in Korea: a population-based study of incidence, mortality, cost and risk factors for death in sepsis. Clin Exp Emerg Med 2019;6:49-63.ArticlePubMedPMCPDF
  • 36. Prajapati C, Koivumäki J, Pekkanen-Mattila M, Aalto-Setälä K. Sex differences in heart: from basics to clinics. Eur J Med Res 2022;27:241. ArticlePubMedPMCPDF
  • 37. Chyou JY, Qin H, Butler J, Voors AA, Lam CS. Sex-related similarities and differences in responses to heart failure therapies. Nat Rev Cardiol 2024;Mar 8; [Epub]. https://doi.org/10.1038/s41569-024-00996-1.Article
  • 38. Merdji H, Long MT, Ostermann M, Herridge M, Myatra SN, De Rosa S, et al. Sex and gender differences in intensive care medicine. Intensive Care Med 2023;49:1155-67.ArticlePubMedPMCPDF
  • 39. Molanorouzi K, Khoo S, Morris T. Motives for adult participation in physical activity: type of activity, age, and gender. BMC Public Health 2015;15:66. ArticlePubMedPMCPDF
  • 40. Białas AJ, Kumor-Kisielewska A, Górski P. Ageing, sex, obesity, smoking and COVID-19: truths, myths and speculations. Adv Respir Med 2020;88:335-42.ArticlePubMed
  • 41. Ghazeeri G, Abdullah L, Abbas O. Immunological differences in women compared with men: overview and contributing factors. Am J Reprod Immunol 2011;66:163-9.ArticlePubMed
  • 42. García-Gómez E, González-Pedrajo B, Camacho-Arroyo I. Role of sex steroid hormones in bacterial-host interactions. Biomed Res Int 2013;2013:928290. PubMed
  • 43. Vázquez-Martínez ER, García-Gómez E, Camacho-Arroyo I, González-Pedrajo B. Sexual dimorphism in bacterial infections. Biol Sex Differ 2018;9:27. PubMedPMC
  • 44. Park DW, Chun BC, Kim JM, Sohn JW, Peck KR, Kim YS, et al. Epidemiological and clinical characteristics of community-acquired severe sepsis and septic shock: a prospective observational study in 12 university hospitals in Korea. J Korean Med Sci 2012;27:1308-14.ArticlePubMedPMCPDF
  • 45. Pietropaoli AP, Glance LG, Oakes D, Fisher SG. Gender differences in mortality in patients with severe sepsis or septic shock. Gend Med 2010;7:422-37.ArticlePubMedPMC
  • 46. Nachtigall I, Tafelski S, Rothbart A, Kaufner L, Schmidt M, Tamarkin A, et al. Gender-related outcome difference is related to course of sepsis on mixed ICUs: a prospective, observational clinical study. Crit Care 2011;15:R151. ArticlePubMedPMC
  • 47. Sakr Y, Elia C, Mascia L, Barberis B, Cardellino S, Livigni S, et al. The influence of gender on the epidemiology of and outcome from severe sepsis. Crit Care 2013;17:R50. ArticlePubMedPMC
  • 48. Sunden-Cullberg J, Nilsson A, Inghammar M. Sex-based differences in ED management of critically ill patients with sepsis: a nationwide cohort study. Intensive Care Med 2020;46:727-36.ArticlePubMedPMCPDF
  • 49. Adrie C, Azoulay E, Francais A, Clec'h C, Darques L, Schwebel C, et al. Influence of gender on the outcome of severe sepsis: a reappraisal. Chest 2007;132:1786-93.ArticlePubMed
  • 50. Xu J, Tong L, Yao J, Guo Z, Lui KY, Hu X, et al. Association of sex with clinical outcome in critically ill sepsis patients: a retrospective analysis of the large clinical database MIMIC-III. Shock 2019;52:146-51.ArticlePubMedPMC
  • 51. Thompson K, Venkatesh B, Hammond N, Taylor C, Finfer S, on behalf of the ADRENAL Investigators, sex-disaggregated analysis Steering Committee. Sex differences in response to adjunctive corticosteroid treatment for patients with septic shock. Intensive Care Med 2021;47:246-8.ArticlePubMedPMCPDF
  • 52. Banta JE, Joshi KP, Beeson L, Nguyen HB. Patient and hospital characteristics associated with inpatient severe sepsis mortality in California, 2005-2010. Crit Care Med 2012;40:2960-6.ArticlePubMed
  • 53. Madsen TE, Simmons J, Choo EK, Portelli D, McGregor AJ, Napoli AM. The DISPARITY Study: do gender differences exist in Surviving Sepsis Campaign resuscitation bundle completion, completion of individual bundle elements, or sepsis mortality? J Crit Care 2014;29:473. Article
  • 54. van Vught LA, Scicluna BP, Wiewel MA, Hoogendijk AJ, Klein Klouwenberg PM, Ong DS, et al. Association of gender with outcome and host response in critically ill sepsis patients. Crit Care Med 2017;45:1854-62.ArticlePubMed
  • 55. Antequera A, Lopez-Alcalde J, Stallings E, Muriel A, Fernández Félix B, Del Campo R, et al. Sex as a prognostic factor for mortality in critically ill adults with sepsis: a systematic review and meta-analysis. BMJ Open 2021;11:e048982.ArticlePubMedPMC
  • 56. Zhang MQ, Macala KF, Fox-Robichaud A, Mendelson AA, Lalu MM, Sepsis Canada National Preclinical Sepsis Platform. Sex- and gender-dependent differences in clinical and preclinical sepsis. Shock 2021;56:178-87.ArticlePubMed
  • 57. Frink M, Pape HC, van Griensven M, Krettek C, Chaudry IH, Hildebrand F. Influence of sex and age on mods and cytokines after multiple injuries. Shock 2007;27:151-6.Article
  • 58. May AK, Dossett LA, Norris PR, Hansen EN, Dorsett RC, Popovsky KA, et al. Estradiol is associated with mortality in critically ill trauma and surgical patients. Crit Care Med 2008;36:62-8.ArticlePubMedPMC
  • 59. Tsang G, Insel MB, Weis JM, Morgan MA, Gough MS, Frasier LM, et al. Bioavailable estradiol concentrations are elevated and predict mortality in septic patients: a prospective cohort study. Crit Care 2016;20:335. ArticlePubMedPMCPDF
  • 60. Feng JY, Liu KT, Abraham E, Chen CY, Tsai PY, Chen YC, et al. Serum estradiol levels predict survival and acute kidney injury in patients with septic shock: a prospective study. PLoS One 2014;9:e97967.ArticlePubMedPMC
  • 61. Reade MC, Yende S, D'Angelo G, Kong L, Kellum JA, Barnato AE, et al. Differences in immune response may explain lower survival among older men with pneumonia. Crit Care Med 2009;37:1655-62.ArticlePubMedPMC
  • 62. Wang HE, Shapiro NI, Griffin R, Safford MM, Judd S, Howard G. Inflammatory and endothelial activation biomarkers and risk of sepsis: a nested case-control study. J Crit Care 2013;28:549-55.ArticlePubMed
  • 63. Modra LJ, Higgins AM, Abeygunawardana VS, Vithanage RN, Bailey MJ, Bellomo R. Sex differences in treatment of adult intensive care patients: a systematic review and meta-analysis. Crit Care Med 2022;50:913-23.Article
  • 64. Todorov A, Kaufmann F, Arslani K, Haider A, Bengs S, Goliasch G, et al. Gender differences in the provision of intensive care: a Bayesian approach. Intensive Care Med 2021;47:577-87.ArticlePubMedPMCPDF

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      • PubReader PubReader
      • ePub LinkePub Link
      • Cite
        CITE
        export Copy
        Close
        Download Citation
        Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

        Format:
        • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
        • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
        Include:
        • Citation for the content below
        Sex or gender differences in treatment outcomes of sepsis and septic shock
        Acute Crit Care. 2024;39(2):207-213.   Published online May 24, 2024
        Close
      • XML DownloadXML Download
      We recommend
      Related articles

      ACC : Acute and Critical Care